Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals in Europe, the Middle East, Africa, the United States, Canada, and internationally. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, gynecology and obstetrics, medical devices, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infectives, central nervous system, endocrinology, gastrointestinal, nutrition and related products, immune-suppressants, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, and radio contrast agent, as well as ear, nose, and throat. It also provides pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy.
Industry, Sector and Symbol
Industry Private households
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone390-248-7871
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.46 billion
Profitability
Miscellaneous
Employees4,142
Next Earnings Date9/26/2019 (Estimated)
OptionableNot Optionable
Recordati (OTCMKTS:RCDTF) Frequently Asked Questions
What is Recordati's stock symbol?
Recordati trades on the OTCMKTS under the ticker symbol "RCDTF."
When is Recordati's next earnings date?
Has Recordati been receiving favorable news coverage?
News headlines about RCDTF stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Recordati earned a coverage optimism score of -1.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Recordati.
Who are some of Recordati's key competitors?
Some companies that are related to Recordati include SMC CORP JAPAN/S (SMCAY), EXPERIAN PLC/ADR (EXPGY), CHINA CITIC BK/ADR (CHCJY), UniCredit (UNCFF), ASSA ABLOY AB/S (ASAZY), A P MOLLER-MAER/ADR (AMKBY), BAE SYS PLC/S (BAESY), SAMPO OYJ/ADR (SAXPY), ASSD BRIT FOODS/ADR (ASBFY), FERROVIAL S A/ADR (FRRVY), WIRECARD AG/ADR (WCAGY), SANDVIK AB/ADR (SDVKY), KERRY GRP PLC/S (KRYAY), MICHELIN COMPAG/ADR (MGDDY) and SECOM LTD/ADR (SOMLY).
Who are Recordati's key executives?
Recordati's management team includes the folowing people:
- Mr. Andrea Recordati, CEO & Director (Age 48)
- Mr. Fritz Squindo, CFO, MD & Exec. Director (Age 63)
- Ms. Marianne Tatschke, Director of Investor Relations & Corp. Communications
- Ms. Daria Ghidoni, Director of Legal Affairs & Group Companies
- Mr. Gabriele Finzi, VP & Director Corp. Devel.
How do I buy shares of Recordati?
Shares of RCDTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Recordati's stock price today?
One share of RCDTF stock can currently be purchased for approximately $34.70.
How big of a company is Recordati?
What is Recordati's official website?
How can I contact Recordati?
Recordati's mailing address is Via Matteo Civitali 1, Milano L6, 20148. The company can be reached via phone at 390-248-7871 or via email at [email protected]
MarketBeat Community Rating for Recordati (OTCMKTS RCDTF)
MarketBeat's community ratings are surveys of what our community members think about Recordati and other stocks. Vote "Outperform" if you believe RCDTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCDTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
